Metformin rescues cell surface major histocompatibility complex class I (MHC-I) deficiency caused by oncogenic transformation (Q39396738)

11 September 2017

Metformin rescues cell surface major histocompatibility complex class I (MHC-I) deficiency caused by oncogenic transformation (English)

1 reference

11 September 2017

1 reference

Begoña Martin-Castillo

6

object named as

Begoña Martin-Castillo

1 reference

11 September 2017

Cristina Oliveras-Ferraros

1

1 reference

11 September 2017

Sílvia Cufí

2

1 reference

11 September 2017

Alejandro Vazquez-Martin

3

1 reference

11 September 2017

Octavio J Menendez

4

1 reference

11 September 2017

Joaquim Bosch-Barrera

5

1 reference

11 September 2017

Jorge Joven

7

1 reference

11 September 2017

Javier A Menendez

8

1 reference

11 September 2017

1 March 2012

1 reference

11 September 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

Cell Cycle

1 reference

11 September 2017

11

1 reference

11 September 2017

5

1 reference

11 September 2017

865-870

1 reference

Molecular mechanisms of MHC class I abnormalities and APM components in human tumors

11 September 2017

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Immunobiological characterization of cancer stem cells isolated from glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

MHC class I antigens, immune surveillance, and tumor immune escape.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Strategies to counteract MHC-I defects in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

IFN inducibility of major histocompatibility antigens in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Oxidative phosphorylation induces de novo expression of the MHC class I in tumor cells through the ERK5 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Tumor suppressors and cell metabolism: a recipe for cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Metformin increases the PGC-1alpha protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

A high-throughput respirometric assay for mitochondrial biogenesis and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb).

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Interferon-gamma renders tumors that express low levels of Her-2/neu sensitive to cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB ligands and remain dependent on the ErbB receptor network

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: Otto Warburg revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Cancer abolishes the tissue type-specific differences in the phenotype of energetic metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Selection of cancer cells with repressed mitochondria triggers colon cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

The mitochondrial bioenergetic capacity of carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

SDHA is a tumor suppressor gene causing paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

p53 regulates mitochondrial respiration

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

Ataxia telangiectasia mutated influences cytochrome c oxidase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.11.5.19252

21 January 2018

Identifiers

DOI

10.4161/CC.11.5.19252

1 reference

11 September 2017

1 reference